135 related articles for article (PubMed ID: 38373778)
1. Treatment of localized hepatocellular carcinoma: resection vs. ablation vs. radiation.
Anderson C; Chin HM; Hoverson J; Court C; Wagner T; Newman NB
Ann Palliat Med; 2024 Mar; 13(2):344-354. PubMed ID: 38373778
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB
Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205
[TBL] [Abstract][Full Text] [Related]
5. Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma.
Luerken L; Haimerl M; Doppler M; Uller W; Beyer LP; Stroszczynski C; Einspieler I
Rofo; 2022 Oct; 194(10):1075-1086. PubMed ID: 35545102
[TBL] [Abstract][Full Text] [Related]
6. Radiation Segmentectomy for Hepatocellular Carcinoma.
Serhal M; Dadrass F; Kim E; Lewandowski RJ
Curr Oncol; 2024 Jan; 31(2):617-628. PubMed ID: 38392039
[TBL] [Abstract][Full Text] [Related]
7. Update on Locoregional Therapies for Liver Cancer: Radiation Segmentectomy.
Dadrass F; Sher A; Kim E
Curr Oncol; 2023 Nov; 30(12):10075-10084. PubMed ID: 38132366
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
[TBL] [Abstract][Full Text] [Related]
9. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
[TBL] [Abstract][Full Text] [Related]
10. Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma.
English K; Brodin NP; Shankar V; Zhu S; Ohri N; Golowa YS; Cynamon J; Bellemare S; Kaubisch A; Kinkhabwala M; Kalnicki S; Garg MK; Guha C; Kabarriti R
JAMA Netw Open; 2020 Nov; 3(11):e2023942. PubMed ID: 33151315
[TBL] [Abstract][Full Text] [Related]
11. Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis.
Rim CH; Lee JS; Kim SY; Seong J
JHEP Rep; 2023 Jan; 5(1):100594. PubMed ID: 36561128
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma.
Ishikawa K; Chiba T; Ooka Y; Suzuki E; Ogasawara S; Maeda T; Yokoyama M; Inoue M; Wakamatsu T; Kusakabe Y; Saito T; Tawada A; Arai M; Kanda T; Maruyama H; Imazeki F; Kato N
Oncotarget; 2018 Apr; 9(30):21560-21568. PubMed ID: 29765560
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
[TBL] [Abstract][Full Text] [Related]
14. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
Xu Z; Xie H; Zhou L; Chen X; Zheng S
Anal Cell Pathol (Amst); 2019; 2019():8619096. PubMed ID: 31534899
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies.
Kimura T; Aikata H; Doi Y; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Katsuta T; Kenjo M; Murakami Y; Awai K; Chayama K; Nagata Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818783450. PubMed ID: 29963972
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Prognostic Factors of Trans-Arterial Chemoembolization Combined With Stereotactic Body Radiation Therapy for BCLC Stage B Hepatocellular Carcinoma.
Jiang C; Jing S; Zhou H; Li A; Qiu X; Zhu X; Shen Z
Front Oncol; 2021; 11():640461. PubMed ID: 34336647
[TBL] [Abstract][Full Text] [Related]
17. Treatment algorithms for managing hepatocellular carcinoma.
Saraswat VA; Pandey G; Shetty S
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S80-9. PubMed ID: 25755616
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
[TBL] [Abstract][Full Text] [Related]
19. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Body Radiation Therapy vs. Transarterial Chemoembolization in Inoperable Barcelona Clinic Liver Cancer Stage a Hepatocellular Carcinoma: A Retrospective, Propensity-Matched Analysis.
Su TS; Liang P; Zhou Y; Huang Y; Cheng T; Qu S; Chen L; Xiang BD; Zhao C; Huang DJ; Liang SX; Li LQ
Front Oncol; 2020; 10():347. PubMed ID: 32266136
[No Abstract] [Full Text] [Related]
[Next] [New Search]